Polar Capital Holdings’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $89.3M | Buy |
|
|||||
|
2025
Q2 | $36.8M | Buy |
|
|||||
|
2025
Q1 | $34.9M | Sell |
|
|||||
|
2024
Q4 | $40.1M | Sell |
|
|||||
|
2024
Q3 | $75.5M | Sell |
|
|||||
|
2024
Q2 | $140M | Sell |
|
|||||
|
2024
Q1 | $170M | Sell |
|
|||||
|
2023
Q4 | $174M | Buy |
|
|||||
|
2023
Q3 | $109M | Hold |
|
|||||
|
2023
Q2 | $95.2M | Hold |
|
|||||
|
2023
Q1 | $109M | Buy |
|
|||||
|
2022
Q4 | $84.8M | Buy |
|
|||||
|
2022
Q3 | $77.5K | Sell |
|
|||||
|
2022
Q2 | $73.9K | Sell |
|
|||||
|
2022
Q1 | $101K | Sell |
|
|||||
|
2021
Q4 | $107K | Hold |
|
|||||
|
2021
Q3 | $103K | Buy |
|
|||||
|
2021
Q2 | $83.8K | Buy |
|
|||||
|
2021
Q1 | $35.5M | Sell |
|
|||||
|
2020
Q4 | $45.9M | Buy |
|